Last reviewed: May 20, 2026

Last updated: May 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Tirzepatide significantly suppresses appetite and alters nutrient absorption, creating real micronutrient depletion risk. Studies show GLP-1 and GIP receptor agonists reduce food intake by 30-40%, directly lowering vitamin and mineral intake unless supplementation is intentional and guided.

PlexusDx supports precision-wellness by integrating genetic predisposition insights with clinical guidance. Understanding your individual nutrient metabolism—informed by biomarker context and genetic factors in peptide pathways—empowers more targeted conversations with your healthcare provider about vitamin strategy during treatment.

How Tirzepatide Affects Vitamin Absorption and Nutrient Status

Tirzepatide works via GLP-1 and GIP receptor activation, slowing gastric emptying and suppressing hunger signals. This mechanism reduces overall food volume consumed, directly decreasing intake of B vitamins, iron, calcium, and other micronutrients even when food quality remains high.

Reduced caloric intake compounds micronutrient risk. Patients on tirzepatide often report 40-50% lower daily calories; over months, this deficit can deplete B12, folate, iron, and vitamin D stores. Regular biomarker monitoring—serum B12, folate, iron studies, 25-OH vitamin D—helps detect subclinical deficiency early.

Critical Vitamins and Minerals During Tirzepatide Therapy

Evidence-based supplementation focuses on nutrients most vulnerable during appetite suppression and calorie reduction. The following table outlines key micronutrients, typical deficiency risk on tirzepatide, and clinical considerations for informed provider discussion.

Nutrient Deficiency Risk on Tirzepatide Typical Dose Range Provider Monitoring Note
Vitamin B12 High—reduced animal protein intake + reduced intrinsic factor activation 1,000–2,000 mcg monthly or weekly Monitor serum B12 and methylmalonic acid annually
Folate (B9) High—reduced leafy green intake, synergistic with B12 depletion 400–800 mcg daily Check folate and homocysteine at baseline and 6 months
Vitamin D (25-OH) Moderate-High—reduced dairy/fortified food intake 2,000–4,000 IU daily or 50,000 IU weekly Target serum 25-OH vitamin D 30–50 ng/mL
Iron Moderate—reduced red meat intake; gender and baseline status dependent Men: monitor only; Women: 18 mg daily if premenopausal Check ferritin, serum iron, TIBC annually
Calcium Moderate—reduced dairy intake 1,000–1,200 mg daily (divided doses) Assess with vitamin D; recheck after 1 year
Magnesium Low-Moderate—varies by baseline diet quality 200–400 mg daily Monitor if experiencing GI side effects or muscle symptoms

The Role of Genetic Predisposition in Nutrient Metabolism

Individual variation in nutrient metabolism is partly genetic. Variants in genes affecting folate metabolism (MTHFR), vitamin D receptor function (VDR), and iron absorption (HFE) influence how efficiently your body processes and stores micronutrients—and how quickly deficiency may develop on tirzepatide.

PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic pathways relevant to GLP-1 and GIP signaling, which can provide context for nutrient-metabolism conversations with your provider. While the test does not predict exact vitamin response, understanding your genetic background may help explain individual differences in supplementation needs during tirzepatide therapy.

Biomarkers That Guide Supplementation Strategy

Before starting tirzepatide, a baseline biomarker panel should include serum B12, folate, vitamin D (25-OH), iron studies (ferritin, serum iron, TIBC), and a complete metabolic panel. These benchmarks allow your provider to detect deficiency early and adjust supplementation based on individual needs, not population averages.

Recheck biomarkers at 3 and 6 months into therapy, then annually. Patients with baseline low-normal B12, genetic variants affecting folate metabolism, or malabsorption history require closer monitoring. Biomarker trends—not single values—guide dosage adjustments and inform whether oral, sublingual, or injectable forms of B12 or other micronutrients may be needed.

Safety Considerations and Who Should Prioritize Supplementation Oversight

Not all patients on tirzepatide require identical supplementation. Those with a history of bariatric surgery, inflammatory bowel disease, pernicious anemia, or baseline micronutrient deficiency face higher depletion risk and need proactive supplementation and monitoring. Patients taking certain medications (metformin, PPIs) may also face synergistic nutrient absorption issues.

Work with your healthcare provider or registered dietitian to personalize a supplementation plan. Excessive supplementation—particularly fat-soluble vitamins (A, D, E, K) and minerals like iron—can cause toxicity. Your provider should document baseline status, recommend specific products (pharmaceutical-grade when possible), and schedule follow-up biomarker testing to confirm adequacy and adjust as needed.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test examines key variants in GLP1R, GIPR, FTO, and MC4R pathways. While these variants influence GLP-1 receptor function and metabolic response, they can also provide context for how your body processes nutrients during tirzepatide therapy. This insight may help you and your provider frame a more individualized supplementation strategy.

The genetic test reveals predispositions in peptide-metabolism pathways, not guaranteed medication response or nutrient absorption capacity. Genetic variants provide one lens; biomarker testing and clinical history provide others. Together, they may help provide context for a more informed conversation with your healthcare provider about which vitamins and minerals warrant closer monitoring during your tirzepatide course.

If you're considering tirzepatide via PlexusDx's compounded formulation, combining genetic predisposition insights with biomarker-guided supplementation creates a precision-wellness framework. Share your genetic results and baseline nutrient status with your prescribing provider to ensure your tirzepatide regimen and supplementation plan are aligned for sustainable weight loss and metabolic health.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves